
Chemical and Pharmaceutical Bulletin p. 1468 - 1473 (1998)
Update date:2022-07-30
Topics:
Suzuki, Takeshi
Nagaoka, Hitoshi
Kondo, Yutaka
Takahashi, Takumi
Takeuchi, Makoto
Hara, Hiromu
Saito, Munetoshi
Yamada, Toshimitsu
Tomioka, Kenichi
Hamada, Mamoru
Mase, Toshiyasu
Conversion of the 2-(3-pyridyl)thiazolidine part of 1-(3-phenylpropyl)- 4-[2-(3-pyridyl)thiazolidine-4-carbonyl]piperazine (YM461), which is a potent platelet-activating factor (PAF) antagonist, to other rings was performed, and PAF antagonistic activitie
View MoreWuhan Fortuna Chemical Co.,Ltd
website:http://www.fortunachem.com
Contact:86-27-59207850
Address:Add: Room 2015, No.2 Building, Kaixin Mansion No.107 Jinqiao Avenue, Wuhan, China
Shanghai HengXun Pharmaceutical Tech. Co., Ltd.
Contact:86-86-52730756
Address:Room 603, No. 240, Tianmuzhong Road, Zhabei, Shanghai, China
Suzhou SuKaiLu Chemical Technology Co., Ltd.
Contact:+86-512-62766020
Address:Floor 4, Building 1, Xinyi Pharmaceutical Valley Wisdom Industrial Park, 415 Changyang Street, Suzhou Industrial Park, Jiangsu Province
Tianjin Hedong Red Cliff Chemical Reagent Factory
Contact:+86-022-84780548
Address:Li Ming Zhuang Gong Ye Yuan,Dongli District,Tianjin,China
Tianjin Tensing Fine Chemical Research Develop Centre
Contact:86-022-23718576,13032267585
Address:2-2-201,13 Guiyuan road,Huayuan Industry district,Tianjin,china
Doi:10.1021/jo000210u
(2000)Doi:10.1021/ol000072v
(2000)Doi:10.1139/v70-348
(1970)Doi:10.1021/ja001958x
(2000)Doi:10.1002/1099-0682(200007)2000:7<1523::AID-EJIC1523>3.0.CO;2-2
(2000)Doi:10.1016/S0040-4039(01)87376-7
(1973)